Which therapy is commonly used to prevent vaginal atrophy in women?

Which therapy is commonly used to prevent vaginal atrophy in women?

• A. Progesterone therapy
• B. Estrogen Replacement Therapy
• C. Oral contraceptives
• D. GnRH agonists

Answer: (B)

Estrogen Replacement Therapy is widely recognized as an effective treatment to prevent vaginal atrophy in women, particularly during menopause and in postmenopausal individuals. Vaginal atrophy, characterized by thinning, drying, and inflammation of the vaginal walls, can result from decreased estrogen levels that often occur during these life stages. Estrogen plays a critical role in maintaining the health and elasticity of vaginal tissues.

By supplementing estrogen, this therapy helps restore the natural moisture and structure of the vaginal lining, thereby alleviating discomfort and reducing the risk of atrophy.

While progesterone therapy is used in certain scenarios related to hormone management, it primarily serves to protect the endometrium in women who are undergoing estrogen therapy and is not designed to target vaginal atrophy directly. Oral contraceptives may influence hormonal balance but do not specifically address vaginal atrophy. GnRH agonists can affect hormone levels and are often used in other contexts, such as endometriosis treatment, but they can actually lead to reductions in estrogen, which may exacerbate vaginal atrophy rather than prevent it. Thus, Estrogen Replacement Therapy stands out as the most suitable choice for preventing this condition.